Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-09-11SPRY144ERIC KARAS plan to sell securities of ARS PHARMACEUTICALS, INC. under Form 144MEDIUM
ERIC KARAS filed Form 144 to notify SEC of plan to sell 14064 units of ARS PHARMACEUTICALS, INC. securities around 2026-09-11, with aggregate market value of $69,761.66. The total outstanding units is 99447343.0. The amount planned to be sold represents 0.01% of total outstanding units; Recent transactions in past 3 mo...
Small CapBiotechnology
2026-09-11AMLX144Klee Justin B. plan to sell securities of Amylyx Pharmaceuticals, Inc. under Form 144MEDIUM
Klee Justin B. filed Form 144 to notify SEC of plan to sell 30464 units of Amylyx Pharmaceuticals, Inc. securities around 2026-09-10, with aggregate market value of $980,264.00. The total outstanding units is 3613056.0. The amount planned to be sold represents 0.84% of total outstanding units; ...
Mid CapBiotechnology
2026-09-11CYTK144ROBERT LANDRY plan to sell securities of CYTOKINETICS, INCORPORATED under Form 144MEDIUM
ROBERT LANDRY filed Form 144 to notify SEC of plan to sell 2000 units of CYTOKINETICS, INCORPORATED securities around 2026-09-11, with aggregate market value of $147,240.00. The total outstanding units is 139023418.0. The amount planned to be sold represents 0.00% of total outstanding units; ...
Large CapBiotechnology
2026-09-11LQDA144RAMANDEEP SINGH plan to sell securities of LIQUIDIA CORPORATION under Form 144MEDIUM
RAMANDEEP SINGH filed Form 144 to notify SEC of plan to sell 9024 units of LIQUIDIA CORPORATION securities around 2026-09-11, with aggregate market value of $619,209.73. The total outstanding units is 89508891.0. The amount planned to be sold represents 0.01% of total outstanding units; ...
Mid CapBiotechnology
2026-09-11SPRY144RICHARD LOWENTHAL plan to sell securities of ARS PHARMACEUTICALS, INC. under Form 144MEDIUM
RICHARD LOWENTHAL filed Form 144 to notify SEC of plan to sell 35000 units of ARS PHARMACEUTICALS, INC. securities around 2026-09-11, with aggregate market value of $176,995.00. The total outstanding units is 99447343.0. The amount planned to be sold represents 0.04% of total outstanding units; Recent transactions in p...
Small CapBiotechnology
2026-09-11MDGL144WILLIAM SIBOLD plan to sell securities of MADRIGAL PHARMACEUTICALS, INC. under Form 144MEDIUM
WILLIAM SIBOLD filed Form 144 to notify SEC of plan to sell 5221 units of MADRIGAL PHARMACEUTICALS, INC. securities around 2026-09-11, with aggregate market value of $2,783,419.52. The total outstanding units is 23104126.0. The amount planned to be sold represents 0.02% of total outstanding units; Recent transactions i...
Large CapBiotechnology
2026-09-11INBX144MANHARD KIMBERLY plan to sell securities of Inhibrx Biosciences, Inc. under Form 144MEDIUM
MANHARD KIMBERLY filed Form 144 to notify SEC of plan to sell 500 units of Inhibrx Biosciences, Inc. securities around 2026-09-11, with aggregate market value of $55,887.50. The total outstanding units is 14717660.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in past ...
Small CapBiotechnology
Sponsored